Intravitreal Interventions®: Volume 10, Number 1

Intravitreal Interventions®: Volume 10, Number 1

Diagnostic techniques and technology in retinal disease continue their rap…

Expiration Date: 6/29/2022

Max Credits: 1.25

View Activity

Revelations in Retinal Vein Occlusion Management – What’s New?

Revelations in Retinal Vein Occlusion Management – What’s New?

Retinal vein occlusions (RVOs) are the second leading cause of vision loss…

Expiration Date: 6/29/2022

Max Credits: 0.75

View Activity

Therapeutic Targeting of the Complement System in Geographic Atrophy

Therapeutic Targeting of the Complement System in Geographic Atrophy

Geographic atrophy (GA) is an advanced form of age-related macular degener…

Expiration Date: 6/24/2022

Max Credits: 0.75

View Activity

Diabetic Macular Edema Management in 2021: What’s New?

Diabetic Macular Edema Management in 2021: What’s New?

Although anti-VEGF therapy has revolutionized the management of diabetic m…

Expiration Date: 6/17/2022

Max Credits: 0.75

View Activity

Neovascular AMD: Impact of Dosing Regimens and Residual Retinal Fluid on Long-Term Outcomes

Neovascular AMD: Impact of Dosing Regimens and Residual Retinal Fluid on Long-Term Outcomes

Intravitreal therapy has rapidly evolved to become a mainstay of treatment…

Expiration Date: 6/15/2022

Max Credits: 0.75

View Activity

The Tie2 Pathway: A New Approach in Retinal Disease?

The Tie2 Pathway: A New Approach in Retinal Disease?

Intravitreal anti-vascular endothelial growth factor (VEGF) therapies have…

Expiration Date: 6/3/2022

Max Credits: 0.75

View Activity

Curbside Consults: Applying Real World Evidence to Practice When Selecting Treatment for nAMD

Curbside Consults: Applying Real World Evidence to Practice When Selecting Treatment for nAMD

Intravitreal therapy has rapidly evolved to become a mainstay of treatment…

Expiration Date: 5/30/2022

Max Credits: 0.25

View Activity

Curbside Consults: Treating nAMD: Getting Past the Burden

Curbside Consults: Treating nAMD: Getting Past the Burden

Intravitreal therapy has rapidly evolved to become a mainstay of treatment…

Expiration Date: 5/30/2022

Max Credits: 0.25

View Activity

Curbside Consults: Long-term Management of nAMD

Curbside Consults: Long-term Management of nAMD

Intravitreal therapy has rapidly evolved to become a mainstay of treatment…

Expiration Date: 5/30/2022

Max Credits: 0.25

View Activity

Curbside Consults on Retinal Vein Occlusion Management: Deciphering New Data on RVO Treatment – How Do they Affect Real-World Practice?

Curbside Consults on Retinal Vein Occlusion Management: Deciphering New Data on RVO Treatment – How Do they Affect Real-World Practice?

Retinal vein occlusions (RVOs) are the second most common retinal vascular…

Expiration Date: 5/30/2022

Max Credits: 0.25

View Activity